Honored to Amplify: Cycle for Survival
Inspire Happiness
Honored to Amplify: Cycle for Survival
2024 / 5 mins
It was an honor to continue our partnership with Cycle for Survival as their 2024 Official Performance Apparel Sponsor, where our combined communities showed up to cycle for an incredible cause at 51 events across 13 cities.
Cycle for Survival is the official rare cancer fundraising program of Memorial Sloan Kettering Cancer Center (MSK). It was started in 2007 by Jennifer Goodman Linn, an MSK sarcoma patient and Equinox member, and her husband, Dave Linn, to give back to MSK and bring hope to people with rare cancer who often don’t have effective treatment options. Since then, their community has raised more than $375 million for rare cancer research at MSK, fueling lifesaving advances benefitting people around the world.
A unique opportunity to unite with other passionate advocates for rare cancer research, Cycle for Survival encompasses more than just the rides—it’s about hope, impact, and the enduring power of rallying to drive change where it’s needed most. Participants share inspiring stories and pay tribute to loved ones while riding, singing, cheering, and supporting each other in whatever way feels right to them.
This marked our second year in a row working with Cycle for Survival–and our most successful yet. More than 23,000 participants gathered at 15 Equinox locations across the country for four hours of high-energy stationary cycling led by Equinox instructors. The result? Over $32 million dollars raised, 100% of which will go toward pioneering rare cancer research, prevention, and detection.
Within six months after the close of the fundraising each year, the money raised by Cycle for Survival participants and donors goes directly to MSK doctors and scientists, fueling bold ideas that could lead to the next big breakthrough in rare cancer treatment.
We are deeply grateful to our community for amplifying awareness through movement and helping to beat rare cancers by donating to a historically underfunded area of research.